US FDA Approves Higher Dose Regeneron Eye Disease Drug Eylea US FDA Approves Higher Dose Regeneron Eye Disease Drug Eylea

US FDA approved a higher-dose version of Regeneron Pharmaceuticals ' drug Eylea for treatment of a disease that is a leading cause of blindness among the elderly, the company said in a statement.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news